Participants were asked to complete questionnaires regarding their cannabis therapy twice during the same session – once for the survey period and again for the period preceding their cannabis treatment. The survey included inquiries about daily pain levels, the intricacies of the cannabinoid prescription process (specifically challenges encountered in obtaining the medication), and participants’ overall attitudes toward cannabis.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…